SHP Wealth Management’s DexCom DXCM Stock Holding History

SHP Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.5K	Buy	215 +24	+13%	+$1.67K	﹤0.01%	825
2025 Q4	$12.7K	Buy	+191	New	+$12.3K	﹤0.01%	778

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SHP Wealth Management's DXCM Position: Q1 2026 in Review

SHP Wealth Management increased its DexCom (DXCM) stake by 13% in Q1 2026, buying an estimated $1.67K and bringing the position to 215 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #825.

SHP Wealth Management first reported a position in DXCM in Q4 2025 and has held it in 2 quarters since. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

SHP Wealth Management held 215 shares of DexCom worth $13.5K as of Q1 2026.
SHP Wealth Management bought 24 DexCom shares in Q1 2026, an estimated $1.67K.
DexCom made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #825 holding.
SHP Wealth Management first reported a position in DexCom in Q4 2025 and has held it in 2 quarters since.
959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.